BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16757300)

  • 1. Development of humanized mice for the study of hepatitis C virus infection.
    Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
    Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
    Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
    Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
    Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
    Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
    J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.
    Kawahara T; Douglas DN; Lewis J; Lund G; Addison W; Tyrrell DL; Churchill TA; Kneteman NM
    Transpl Int; 2010 Sep; 23(9):934-43. PubMed ID: 20180929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
    Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
    Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
    Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
    J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-stage development of Plasmodium falciparum, in a humanized mouse model.
    Morosan S; Hez-Deroubaix S; Lunel F; Renia L; Giannini C; Van Rooijen N; Battaglia S; Blanc C; Eling W; Sauerwein R; Hannoun L; Belghiti J; Brechot C; Kremsdorf D; Druilhe P
    J Infect Dis; 2006 Apr; 193(7):996-1004. PubMed ID: 16518762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
    Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.
    Dandri M; Burda MR; Török E; Pollok JM; Iwanska A; Sommer G; Rogiers X; Rogler CE; Gupta S; Will H; Greten H; Petersen J
    Hepatology; 2001 Apr; 33(4):981-8. PubMed ID: 11283864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
    Ohshita H; Tateno C
    Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
    Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of humanized animal livers using embryoid body-derived stem cell transplant.
    Locke JE; Sun Z; Warren DS; Sheets TP; Holzer H; Shamblott MJ; Montgomery RA; Cameron AM
    Ann Surg; 2008 Sep; 248(3):487-93. PubMed ID: 18791369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus replication in mice with chimeric human livers.
    Mercer DF; Schiller DE; Elliott JF; Douglas DN; Hao C; Rinfret A; Addison WR; Fischer KP; Churchill TA; Lakey JR; Tyrrell DL; Kneteman NM
    Nat Med; 2001 Aug; 7(8):927-33. PubMed ID: 11479625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near completely humanized liver in mice shows human-type metabolic responses to drugs.
    Tateno C; Yoshizane Y; Saito N; Kataoka M; Utoh R; Yamasaki C; Tachibana A; Soeno Y; Asahina K; Hino H; Asahara T; Yokoi T; Furukawa T; Yoshizato K
    Am J Pathol; 2004 Sep; 165(3):901-12. PubMed ID: 15331414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.
    Dandri M; Burda MR; Zuckerman DM; Wursthorn K; Matschl U; Pollok JM; Rogiers X; Gocht A; Köck J; Blum HE; von Weizsäcker F; Petersen J
    J Hepatol; 2005 Jan; 42(1):54-60. PubMed ID: 15629507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.